share_log
Reuters ·  Feb 25 13:00
Evaxion Extends Phase 2 Trial With Personalized Cancer Vaccine Evx-01 to Further Enhance Clinical Data Package
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
Comment Comment · Views 398

Recommended

Write a comment